T2 said it's in a strong position to achieve planned portfolio milestones over the next two years, including submitting its next test for FDA clearance next year.
C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.
A new PGen study reports that nearly 6 percent of consumers made changes to their prescription medication based on pharmacogenomic testing.
Called the Roberts Collaborative for Genetics and Individualized Medicine, the program was established with a $25 million gift from Comcast CEO Brian Roberts and members of his family.
A recent study examining the websites of 30 DTC genomics firms found that many do not follow international recommendations for disclosing information to customers.
In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.
The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.
The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.
Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."